Hazelwood, MO, United States of America

Gary Nichols

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Specgx LLC. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gary Nichols. Retrieved from https://idiyas.com/inventor/gary-nichols

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Mind of Gary Nichols

Introduction

Gary Nichols, an esteemed inventor based in Hazelwood, MO, has made a significant impact in the field of pharmaceuticals with his innovative approaches to medication formulation. With a total of three patents to his name, Nichols is recognized for developing advanced dosage forms that prioritize safety and efficacy.

Latest Patents

Among Nichols' latest contributions are his patents for extended release, abuse deterrent dosage forms. These innovations comprise crush-resistant controlled-release particles designed to provide abuse deterrent properties to the dosage forms. The unique formulation includes plastic and elastic polymers combined with at least one active pharmaceutical ingredient (API) or a pharmaceutically acceptable salt thereof. Notably, these particles are prepared through a hot melt extrusion process, marking a significant advancement in the development of safer medication options.

Career Highlights

As a dedicated member of Specgx LLC, Gary Nichols continues to push the boundaries of pharmaceutical innovation. His commitment to creating safe and effective medications highlights his dedication to improving patient outcomes and ensuring drug safety.

Collaborations

Throughout his career, Nichols has collaborated with talented colleagues, including Jonathan Gaik and Jaehan Park. These partnerships have played a crucial role in the success of his projects, allowing for the exchange of ideas and expertise in the field of pharmaceutical research.

Conclusion

Gary Nichols exemplifies the spirit of innovation in the pharmaceutical industry, with his significant contributions aimed at enhancing medication safety through advanced formulation techniques. As he continues his work at Specgx LLC, the impact of his inventions is expected to resonate within the healthcare community and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…